Redistributed Manufacturing Research

There are a number of drivers underpinning the exploration and adoption of redistributed manufacturing in healthcare. These include the risk of committed capital, increasing complexity of existing supply chains, the challenge of managing capacity, the need for greater sustainability, and the adoption of new technologies that allow greater tailoring of treatments to individuals and manufacture to demand.

However, the impact of implementing RDM technologies, systems and strategies are not fully understood. In close collaboration with healthcare stakeholders, RiHN seeks to advance the understanding of this phenomenon in a number of ways, these include:

  • Commissioning feasibility studies that seek to make healthcare solutions more effective and or available/affordable
  • Stimulating collaboration and knowledge transfer between relevant Academic-Industry-User communities
  • Identifying the systemic dependencies (e.g. skills and training requirements, regulatory aspects) that affect the take up of RDM applications in healthcare
  • Presenting guidance on pathways for future RDM innovations in healthcare
  • Capturing expert stakeholder views and recommendations for future research directions and investment

In 2015 the RiHN team ran sandpit workshops in Bristol and Nottingham exploring potential feasibility study topics. Please refer to the below links for more details and the final report and findings:

RiHN Introductory presentations

 

RiHN Sandpit Workshops in Bristol (March 2015) and Nottingham (April 2015)

Facebooktwittergoogle_plusredditpinterestlinkedinmail